{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:35:10Z","timestamp":1735583710081},"reference-count":24,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.16-044","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T18:06:16Z","timestamp":1471284376000},"page":"640-644","source":"Crossref","is-referenced-by-count":9,"title":["A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy"],"prefix":"10.1536","volume":"57","author":[{"given":"Makiko","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osahiko","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hokama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Miyara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Taba","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Touma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Prefectural Nanbu Medical Center and Children\u2019s Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687-95. (Review)","DOI":"10.1016\/S0140-6736(02)07815-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ishikawa Y, Back J, Minami R. Cardioprotection for Duchenne\u2019s muscular dystrophy. Am Heart J 1999; 137: 895-902.","DOI":"10.1016\/S0002-8703(99)70414-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Doing AH, Renlund DG, Smith RA. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy. J Heart Lung Transplant 2002; 21: 496-8.","DOI":"10.1016\/S1053-2498(01)00316-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Moxley RT 3rd, Ashwal S, Pandya S, <i>et al<\/i>. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005; 64: 13-20.","DOI":"10.1212\/01.WNL.0000148485.00049.B7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schram G, Fournier A, Leduc H, <i>et al<\/i>. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 2013; 61: 948-54.","DOI":"10.1016\/j.jacc.2012.12.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Finsterer J, St\u00f6llberger C. Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 2008; 24: 786-92. (Review)","DOI":"10.1016\/S0828-282X(08)70686-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chrzanowski L, Kasprzak JD, Trzos E, <i>et al<\/i>. Different expression of X-linked cardiomyopathy in monozygotic triplets with Becker\u2019s dystrophy. Int J Cardiovasc Imaging 2003; 19: 377-80.","DOI":"10.1023\/A:1025824105194"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Melacini P, Fanin M, Danieli GA, <i>et al<\/i>. Myocardial involvement is very frequent among patients affected with subclinical Becker\u2019s muscular dystrophy. Circulation 1996; 94: 3168-75.","DOI":"10.1161\/01.CIR.94.12.3168"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhou J, Gao J, Zhang X, <i>et al<\/i>. microRNA-340-5p functions downstream of cardiotrophin-1 to regulate cardiac eccentric hypertrophy and heart failure via target gene dystrophin. Int Heart J 2015; 56: 454-8.","DOI":"10.1536\/ihj.14-386"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hashimoto A, Naito AT, Lee JK, <i>et al<\/i>. Generation of induced pluripotent stem cells from patients with Duchenne muscular dystrophy and their induction to cardiomyocytes. Int Heart J 2016; 57: 112-7.","DOI":"10.1536\/ihj.15-376"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishikawa Y, Back J, Minami R. Cardioprotection for Duchenne\u2019s muscular dystrophy. Am Heart J 1999; 137: 895-902.","DOI":"10.1016\/S0002-8703(99)70414-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fayssoil A, Nardi O, Orlikowski D, Annane D. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev 2010; 15: 103-7. (Review)","DOI":"10.1007\/s10741-009-9156-8"},{"key":"13","unstructured":"13. Fayssoil A, Abasse S. Cardiac resynchronization therapy in Becker muscular dystrophy: for which patients? Hellenic J Cardiol 2010; 51: 377-8."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. St\u00f6llberger C, Finsterer J. Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging. Heart Lung 2005; 34: 317-20.","DOI":"10.1016\/j.hrtlng.2005.03.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wu RS, Gupta S, Brown RN, <i>et al<\/i>. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant 2010; 29: 432-8.","DOI":"10.1016\/j.healun.2009.08.030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008; 1: CD003725.","DOI":"10.1002\/14651858.CD003725.pub3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Finsterer J, Bittner RE, Grimm M. Cardiac involvement in Becker\u2019s muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord 1999; 9: 598-600.","DOI":"10.1016\/S0960-8966(99)00045-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Silversides CK, Webb GD, Harris VA, Biggar DW. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 2003; 91: 769-72.","DOI":"10.1016\/S0002-9149(02)03429-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hor KN, Mazur W, Taylor MD, <i>et al<\/i>. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Caridovasc Magn Reson 2011; 13: 60.","DOI":"10.1186\/1532-429X-13-60"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 2005; 26: 768-71.","DOI":"10.1007\/s00246-005-0909-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 2008; 18: 365-70.","DOI":"10.1016\/j.nmd.2008.03.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193-208.","DOI":"10.1002\/ana.410160206"},{"key":"23","unstructured":"23. Moriuchi T, Kagawa N, Mukoyama M, Hizawa K. Autopsy analyses of the muscular dystrophies. Tokushima J Exp Med 1993; 40: 83-93."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-1998: A 22-year-old man with a cardiac transplant and creatine kinase elevation. N Engl J Med 1998; 339: 182-90.","DOI":"10.1056\/NEJM199807163390308"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/5\/57_16-044\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T11:33:26Z","timestamp":1568288006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/5\/57_16-044\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-044","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}